MicroTransponder CEO Will Rosellini Named Graduate Student Entrepreneur of the Year by the Entrepreneurs’ Organization
MicroTransponder CEO Will Rosellini named Graduate Student Entrepreneur of the Year by the Entrepreneurs’ Organization for founding a dynamic medical device company focused on neurostimulation for chronic pain and other neurological disorders.
Dallas, TX, November 20, 2009 --(PR.com)-- Will Rosellini, the CEO of MicroTransponder Inc., a privately-held medical device company developing a suite of wireless neuroneuroprostheses, has just been awarded the title of Graduate Student Entrepreneur of the Year by the Entrepreneurs’ Organization (EO) at the Global Student Entrepreneur Awards (GSEA).
Rosellini was recognized for his vision and drive to create a dynamic neurostimulation company that is developing products to treat a range of neurological disorders including tinnitus, stroke, Parkinson’s disease, and chronic pain. Raising substantial amounts of capital and multiple NIH grants, Rosellini has shown remarkable skill in managing several neuroscience research initiatives to develop new products that are commercially viable. More impressively, he has run the company while simultaneously working on his PhD in Neuroscience at the University of Texas at Dallas.
Rosellini began his professional career far from the neuroscience lab, as a baseball player for the Arizona Diamondbacks. He then went back to school to earn a JD, MBA, Masters of Computational Biology, and a Masters of Neuroscience. One of the distinguished executives attending the GSEA was Alfredo Molina, founder of Molina Fine Jewelers. Molina stated, “As owner of the Arizona Diamondbacks and supporter of the Entrepreneur's Organization, I was very pleased to see a former Diamondback player flourish as an entrepreneur.” The GSEA is the premier global competition for students, supported by the Ewing Marion Kauffman Foundation. Competitors from 27 countries competed this year for the title of Entrepreneur of the Year.
MicroTransponder is Rosellini’s second startup. The business plan for his first venture, which he successfully built and sold, was written when he was an MBA student in Dr. Joseph Picken’s entrepreneurship class. Dr. Picken, currently the Executive Director of UTD’s nationally recognized Institute for Innovation and Entrepreneurship, said “it was clear, when Rosellini was a student, that he had an exceptional talent for entrepreneurship. It is a great delight to see a student achieve the level of success that Rosellini has enjoyed, not once, but twice before he attained the age of 30. All of us at UT Dallas are rightfully proud of what he has accomplished.”
About MicroTransponder, Inc.
MicroTransponder ( www.microtransponder.com) is developing a wireless neurostimulation system for the treatment of chronic pain and several other neurological indications. The minimally invasive device will provide relief from chronic pain without requiring an implanted battery or wires. The company is finalizing R&D on the device and accumulating data toward FDA clearance. MicroTransponder also is adapting the system for Vagus Nerve Stimulation to create a pipeline of innovative treatments for other neurological indications, including stroke rehabilitation, tinnitus, autism, and Parkinson’s disease.
About the Institute for Innovation and Entrepreneurship at UT Dallas
The Institute for Innovation & Entrepreneurship at UT Dallas was established in 2006 as a collaborative initiative of the seven schools of the university. The institute and its academic programs within the UT Dallas School of Management were recently recognized as one of the nation’s leading entrepreneurship programs, cited for “outstanding contributions to advance the discipline of entrepreneurship” at the 2009 annual meeting of the Global Consortium of Entrepreneurship Centers (GCEC). This recognition complements the 2008 recognition as a Tech Titan for “outstanding leadership in the Dallas/Fort Worth technology community through assisting, enabling or accelerating the performance of technology companies or organizations.”
###
Rosellini was recognized for his vision and drive to create a dynamic neurostimulation company that is developing products to treat a range of neurological disorders including tinnitus, stroke, Parkinson’s disease, and chronic pain. Raising substantial amounts of capital and multiple NIH grants, Rosellini has shown remarkable skill in managing several neuroscience research initiatives to develop new products that are commercially viable. More impressively, he has run the company while simultaneously working on his PhD in Neuroscience at the University of Texas at Dallas.
Rosellini began his professional career far from the neuroscience lab, as a baseball player for the Arizona Diamondbacks. He then went back to school to earn a JD, MBA, Masters of Computational Biology, and a Masters of Neuroscience. One of the distinguished executives attending the GSEA was Alfredo Molina, founder of Molina Fine Jewelers. Molina stated, “As owner of the Arizona Diamondbacks and supporter of the Entrepreneur's Organization, I was very pleased to see a former Diamondback player flourish as an entrepreneur.” The GSEA is the premier global competition for students, supported by the Ewing Marion Kauffman Foundation. Competitors from 27 countries competed this year for the title of Entrepreneur of the Year.
MicroTransponder is Rosellini’s second startup. The business plan for his first venture, which he successfully built and sold, was written when he was an MBA student in Dr. Joseph Picken’s entrepreneurship class. Dr. Picken, currently the Executive Director of UTD’s nationally recognized Institute for Innovation and Entrepreneurship, said “it was clear, when Rosellini was a student, that he had an exceptional talent for entrepreneurship. It is a great delight to see a student achieve the level of success that Rosellini has enjoyed, not once, but twice before he attained the age of 30. All of us at UT Dallas are rightfully proud of what he has accomplished.”
About MicroTransponder, Inc.
MicroTransponder ( www.microtransponder.com) is developing a wireless neurostimulation system for the treatment of chronic pain and several other neurological indications. The minimally invasive device will provide relief from chronic pain without requiring an implanted battery or wires. The company is finalizing R&D on the device and accumulating data toward FDA clearance. MicroTransponder also is adapting the system for Vagus Nerve Stimulation to create a pipeline of innovative treatments for other neurological indications, including stroke rehabilitation, tinnitus, autism, and Parkinson’s disease.
About the Institute for Innovation and Entrepreneurship at UT Dallas
The Institute for Innovation & Entrepreneurship at UT Dallas was established in 2006 as a collaborative initiative of the seven schools of the university. The institute and its academic programs within the UT Dallas School of Management were recently recognized as one of the nation’s leading entrepreneurship programs, cited for “outstanding contributions to advance the discipline of entrepreneurship” at the 2009 annual meeting of the Global Consortium of Entrepreneurship Centers (GCEC). This recognition complements the 2008 recognition as a Tech Titan for “outstanding leadership in the Dallas/Fort Worth technology community through assisting, enabling or accelerating the performance of technology companies or organizations.”
###
Contact
MicroTransponder Inc.
Jordan Curnes
214-770-0935
www.microtransponder.com
Jordan Curnes
214-770-0935
www.microtransponder.com
Contact
Categories